「product」の検索結果
168件：161～165件目を表示
-
marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Ja...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; Pr...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 February Reishin Tanimura became ...
https://www.senju.co.jp/english/about/history.html -
® Ophthalmic suspension 0.3%” (Generic Name: Motugivatrep, development code: SJP-0132, hereinafter: Product), discovered and licensed by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; Pr...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Ja...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf